Quotient Therapeutics is a Biotech company based in Cambridge, MA. It has raised $50M in total funding. Latest round: Seed. Backed by Flagship Pioneering.
Quotient Therapeutics funding overview
Quotient Therapeutics is a Biotech company based in Cambridge, MA. Quotient Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in January 2022. The round record for Quotient Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Flagship Pioneering.
Quotient Therapeutics at a glance
Total raised
$50M
Latest round
Seed
Latest round date
January 2022
Industry
Biotech
Headquarters
Cambridge, MA
Notable investors
Flagship Pioneering
Frequently asked about Quotient Therapeutics funding
How much has Quotient Therapeutics raised?
Quotient Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Quotient Therapeutics?
Flagship Pioneering are named among the investors backing Quotient Therapeutics.
What was the latest Quotient Therapeutics funding round?
The most recent disclosed round is a Seed, announced in January 2022.
Where is Quotient Therapeutics based?
Quotient Therapeutics is based in Cambridge, MA.
What sector does Quotient Therapeutics operate in?
Quotient Therapeutics is tracked under Biotech from Cambridge, MA, with $50M in disclosed funding.
When did Quotient Therapeutics last raise?
The last disclosed Quotient Therapeutics round closed in January 2022 at Seed.
Every Quotient Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Cambridge at a similar stage.
